UNSPSC 51283511: Dicloxacillin sodium monohydrate

This classification denotes a penicillin antibiotic with the molecular formula C19H16Cl2N3O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4HZT2V9KX0, chemically known as 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but more generally known as dicloxacillin sodium, which bears US NIH Compound Identifier 6098.

European Medicines Agency schedules Dicloxacillin sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11900MIG. Most nations, for tariff and trade purposes, schedule dicloxacillin sodium monohydrate under HS 29411090 and SITC 54131. SMILES: CC1C(C(NO1)C2C(CCCC2CL)CL)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)[O-].O.[NA+].

UNSPSC 51283511 Dicloxacillin sodium monohydrate is a Commodity code that in practice covers a much broader range of pharmaceutical and medical supply procurement than its specific drug name suggests. State and local governments use this code to solicit generic pharmaceuticals, over-the-counter products, emergency medical supplies, and naloxone/opioid-response medications through both direct purchases and cooperative purchasing agreements. Issuing bodies span state health and human services departments, city fire and rescue divisions, county health departments, and multistate cooperative purchasing alliances. The work involves competitive bidding for established product lines with firm pricing, compliance with FDA and manufacturing standards, supply-chain management through authorized wholesalers, and quarterly or on-demand delivery to municipal and county health facilities.

Recent activity concentrates in Florida, Texas, and Minnesota. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities including Oregon, with proposals evaluated on fixed pricing (10 percent), compliance and EDI capability (10 percent combined), and price competitiveness (75 percent). The City of Tampa's Purchasing Department solicited sealed bids in March 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000, designated as a sheltered market opportunity with a 5 percent SLBE bid discount not to exceed $10,000. Seminole County, Florida issued an IFB in June 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, potentially funded through FEMA. Texas Health and Human Services Commission posted an RFI in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs and vendor capacity for self-insured employer contracting outside traditional pharmacy benefit manager arrangements.